Renaud Ronald C JR bought KLRA
June 9, 2026 · Form 4 insider transaction
Renaud Ronald C JR bought 38,094 shares of Kailera Therapeutics, Inc. at $5.25 per share, a transaction worth $200.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
38,094
Price
$5.25
Total value
$200.0K
InsiderRenaud Ronald C JR
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 9, 2026
Filing dateJune 11, 2026
Shares owned after38,094
OwnershipDirect
10b5-1 planNo
AmendedNo